Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2004

View Archived Issues

Traditional Chinese medicine shows neuroprotective effects in vivo

Chinese herb derivative attenuates neuronal damage in diabetic mice

Ista submits sNDA for Vitrase as spreading agent

New formulation of Solon launched in Japan

Lonza to manufacture Dynepo

Mycobacterial cell wall-DNA complex may present vaccine potential against bladder carcinoma

Subgroup analysis of FOCUS study in ADHD

Topline results from Opterone study

Inactine phase III study progresses

FDA clearance for Captia HSV IgG Specific ELISAs

Canadian NDS filing for Histrelin Hydrogel Implant

Hybridon licenses VEGF rights to Alnylam for ocular indications

Preclinical animal safety studies completed for CytoGenix' antiherpes compound

Cubicin phase III study cleared to continue after third safety review

First chemotherapy combination study for KRX-0401

Progression of ASCENT trial of DN-101 plus Taxotere for AIPC

Bioxalis expands pipeline

Chemotherapeutic agents target microtubules synergistically

Two series of vanilloid VR1 antagonists prepared and tested at Neurogen

New 5-HT receptor antagonists with potential as antidepressants claimed by Abbott

Novel thrombopoietin mimetics under development at GSK

Two series of NPY Y5 antagonists presented by Pfizer scientists

BMS scientists design new HER inhibitors for cancer therapy

New cathepsin inhibitors covered by AstraZeneca patent

Pfizer researchers identify novel chemokine CCR1 antagonists

EP-2104R MRI contrast agent enters clinical testing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...